Novo Nordisk’s Wegovy Pill Becomes First FDA-Approved Oral GLP-1 Drug for Weight Loss / MedCity
Frank Vinluan / medcitynews - Beyond weight reduction and long-term maintenance of weight loss, the FDA decision for oral Wegovy covers use of the once-daily pill for reducing the risk of major cardiovascular events. Novo Nordisk expects the Wegovy tablet will launch in early January.…
#obesity #healthcare #pharmaceuticals #novonordisk #weightloss #drugdevelopment #fda
2 months / medicalxpress
2 months / medcitynews / Frank Vinluan
2 months / medicalxpress
2 months / medcitynews / Chris Plance
2 months / medcitynews / Shantanu Gaur
2 months / nature / Mary E. Rinella
2 months / nature / Andreea Ciudin
2 months / endpoints / Elizabeth Cairns
2 months / endpoints / Elizabeth Cairns
2 months / medcitynews / Myra Ahmad
2 months / nature / Rima M. Chakaroun
2 months / fiercehealthcare
2 months / medcitynews / Frank Vinluan
2 months / endpoints / Elizabeth Cairns
Tuesday, December 23, 2025, 3:22 pm / permalink 17254 / 36 stories in 2 months